Biopsy Devices Market Analysis
ID: MRFR/MED/1652-CR
80 Pages
March 2023
Biopsy Devices Market Research Report Information By Product Type (Biopsy Guns, Biopsy Guidance System, Biopsy Needles [Vacuum-Assisted Biopsy (VAB) Devices, Fine Needle Aspiration Biopsy (FNAB) Devices, Core Needle Biopsy (CNB) Devices], Biopsy Forceps, Localization Wires, and Others), By Application (Breast Biopsy, Prostate Biopsy, Liver Biopsy, Lung Biopsy, Gynecological Biopsy, and Others),...
Market Summary
As per Market Research Future Analysis, the Biopsy Devices Market was valued at USD 2.81 billion in 2024 and is projected to reach USD 5.18 billion by 2035, growing at a CAGR of 5.72% from 2025 to 2035. The market growth is driven by the rising prevalence of cancer and the increasing preference for minimally invasive surgeries. Key players include Argon Medical Devices, BD, Cook Medical, and Hologic, among others. The market is characterized by intense competition and rapid technological advancements.
Key Market Trends & Highlights
The Biopsy Devices Market is witnessing significant growth due to various factors.
- Market Size in 2024: USD 2.81 billion; projected to grow to USD 4.4 billion by 2032. CAGR from 2025 to 2035: 5.72%; driven by increasing cancer prevalence. Breast biopsy segment accounted for the largest share in 2022; expected to grow fastest through 2030. North America holds the largest market share; Asia-Pacific expected to grow at the highest rate.
Market Size & Forecast
| 2024 Market Size | USD 2.81 Billion |
| 2035 Market Size | USD 5.18 Billion |
| CAGR (2024-2035) | 5.72% |
| Largest Regional Market Share in 2024 | North America. |
Major Players
<p>Argon Medical Devices, BD, Cook Medical, CONMED Corporation, Olympus Corporation, Hologic, Inc., Cardinal Health Inc., Integra LifeSciences, Medtronic plc, Mammotome, INRAD, Trivitron Healthcare.</p>
Market Trends
Rising prevalence of cancer to boost market growth
A biopsy is a type of diagnostic procedure used to find both malignant and non-cancerous abnormalities in the human body. The global market for biopsy devices is projected to expand due to the rising incidence of cancer in the population. For instance, cancer is the second-leading cause of death in the US after heart disease and is the primary cause of death in Canada. According to the American Cancer Society, there were 693,000 cancer fatalities and 1.9 million new cancer diagnoses in 2018.
In North America, prostate cancer is the disease that is most frequently diagnosed in men, but breast cancer continues to be the most common cancer in women. Lung cancer continues to be the leading cause of death in both sexes. One of the main causes of the population's cancer incidences rising is the rapid change in lifestyle, as well as the intake of alcohol and cigarette products. Boston Scientific Corporation, BD, Qiagen, F. Hoffman La-Roche Ltd., Hologic, and other significant manufacturers of biopsy instruments and related products for the diagnosis of cancer and other disorders.
Hence, it is anticipated that the global market for biopsy instruments will expand due to the rising incidence of cancer worldwide.
<p>The ongoing advancements in biopsy devices indicate a transformative shift towards minimally invasive techniques, enhancing diagnostic accuracy and patient outcomes in the healthcare sector.</p>
U.S. Food and Drug Administration (FDA)
Biopsy Devices Market Market Drivers
Market Growth Projections
The Global Biopsy Devices Market Industry is poised for substantial growth, with projections indicating a market value of 5.2 USD Billion by 2035. This growth is underpinned by a compound annual growth rate of 5.75% from 2025 to 2035, reflecting increasing demand for biopsy procedures across various medical fields. The expansion of healthcare facilities and advancements in technology are likely to drive this trend, as healthcare providers seek efficient and effective diagnostic solutions. The market's trajectory suggests a robust future, characterized by innovation and enhanced patient care.
Rising Incidence of Cancer
The increasing prevalence of cancer globally is a primary driver for the Global Biopsy Devices Market Industry. As cancer cases rise, the demand for accurate diagnostic tools, including biopsy devices, intensifies. For instance, the World Health Organization indicates that cancer is one of the leading causes of death worldwide, necessitating early detection and intervention. This trend is expected to propel the market, with projections suggesting a market value of 2.81 USD Billion in 2024, reflecting the urgent need for effective biopsy solutions.
Technological Advancements
Innovations in biopsy technologies significantly enhance the capabilities of the Global Biopsy Devices Market Industry. Advanced imaging techniques, such as MRI and CT-guided biopsies, improve precision and reduce patient discomfort. Additionally, the development of minimally invasive biopsy devices, such as core needle and vacuum-assisted systems, allows for quicker recovery times and better patient outcomes. These advancements are likely to attract healthcare providers, contributing to a projected market growth to 5.2 USD Billion by 2035, indicating a robust demand for cutting-edge biopsy solutions.
Growing Geriatric Population
The aging population worldwide is a crucial factor driving the Global Biopsy Devices Market Industry. Older adults are at a higher risk for various diseases, including cancer, thereby increasing the need for diagnostic procedures like biopsies. According to demographic studies, the global population aged 65 and older is expected to reach 1.5 billion by 2050. This demographic shift is likely to result in a heightened demand for biopsy devices, supporting a compound annual growth rate of 5.75% from 2025 to 2035, as healthcare systems adapt to the needs of an aging society.
Increased Healthcare Expenditure
Rising healthcare expenditure across various regions is propelling the Global Biopsy Devices Market Industry. Governments and private sectors are investing more in healthcare infrastructure, leading to improved access to diagnostic services. For example, countries in North America and Europe are allocating substantial budgets to enhance cancer screening programs, which include biopsy procedures. This increase in funding is likely to facilitate the adoption of advanced biopsy technologies, contributing to the market's growth trajectory, with expectations of reaching 5.2 USD Billion by 2035.
Regulatory Approvals and Support
The role of regulatory bodies in approving and supporting advanced biopsy devices is pivotal for the Global Biopsy Devices Market Industry. Regulatory agencies, such as the FDA, are streamlining the approval processes for innovative biopsy technologies, thereby encouraging manufacturers to invest in research and development. This supportive regulatory environment fosters innovation and enhances market entry for new products. As a result, the market is poised for growth, with a projected value of 2.81 USD Billion in 2024, reflecting the positive impact of regulatory initiatives on the industry.
Market Segment Insights
Biopsy Devices Market Product Type Insights
Biopsy Devices Product Type Insights
<p>The Market segments of Biopsy Devices, based on product type, includes biopsy guns, biopsy guidance system, biopsy needles, biopsy forceps, localization wires, and others. The biopsy guns segment accounted for the largest share in 2022 and the biopsy needle segment is anticipated to be the fastest growing for the forecast period 2023-2030. Over the forecast period, a surge in demand for these weapons to collect samples from internal organs' soft tissues, such as kidneys, breasts, and lungs, is anticipated to support the market's overall expansion.</p>
<p>One of the main elements supporting the segment's growth is the increasing demand for quick and delicate cell sample collection for biopsies.</p>
<p>Figure 2: Biopsy Devices Market, by Product Type, 2023 & 2030 (USD Billion)</p>
Biopsy Devices Application Insights
<p>Based on application, the global Biopsy Devices industry has been segmented into breast biopsy, prostate biopsy, liver biopsy, lung biopsy, gynecological biopsy, and others. The breast biopsy segment accounted for the largest share in 2022 and is anticipated to be the fastest growing for the forecast period 2023-2030. This is due to the rise in breast cancer cases that has been seen over the years and is predicted to continue in the coming years. At the moment, breast cancer can be detected effectively and quickly using modern biopsy tools.</p>
<p>The demand for the usage of biopsy equipment has increased globally due to increased public awareness of disease screening and technological advancements in biopsy devices.</p>
<p>May 2021</p>
Biopsy Devices Guidance Technique Insights
<p>Based on guidance technique, the global market of biopsy devices has been categorized into ultrasound-guided biopsy, stereotactic guided biopsy, MRI-guided biopsy, CT guided biopsy, and others. The CT guided biopsy segment accounted for the largest share in 2022 and is anticipated to be the fastest growing for the forecast period 2023-2030. The market for ultrasound-guided biopsies is anticipated to grow at the highest CAGR during the forecast period due to the growing use of this technique for cancer detection in diagnostic laboratories as well as its many advantages and diverse applications.</p>
<p>These advantages include high throughput, high efficiency, accuracy, and minimal invasiveness, all of which are anticipated to fuel this segment's market expansion.</p>
Biopsy End User Insights
<p>Based on end user, the global market biopsy devices has been categorized into hospitals & clinics, diagnostic & imaging centers, academic & research institutes, and others. The hospitals & clinics segment accounted for the largest share in 2022 and is anticipated to be the fastest growing for the forecast period 2023-2030. Due to the wide availability of cutting-edge medical equipment and reimbursement policies, the hospitals & clinics market segment controlled over 68% of the global market share for biopsy instruments.</p>
<p>The National Average Medicare rate for breast biopsy operations with the implantation of a breast localization device in hospitals was around USD 1,400 in 2021, according to the coding and reimbursement guide from Hologic. The number of surgical procedures performed in hospitals will increase as a result of these variables, which will increase the use of biopsy medical equipment.</p>
Get more detailed insights about Biopsy Devices Market Research Report - Global Forecast to 2032
Regional Insights
By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. The growth of the North America Biopsy Devices market is attributed to the high market penetration rates of cutting-edge products, like vacuum-assisted biopsy systems, and a quickly rising market demand for disposable products.
Further, the major countries studied are: the U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: BIOPSY DEVICES MARKET SIZE BY REGION 2023 & 2030 (USD Billion)
Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review
North America Biopsy Devices market accounts for the largest market share due to the presence of well-established market players in the nation, high market penetration rates of cutting-edge products, like vacuum-assisted biopsy systems, and a quickly rising market demand for disposable products. Furthermore, the US market of Biopsy Devices held the largest market share and the Canada market of Biopsy Devices accounted for the second largest market in North America.
The inclination for minimally invasive procedures, an increase in cancer incidence globally, and government initiatives for diagnosis in this region are the driving forces behind the growth of the biopsy instruments market.
The Asia-Pacific Biopsy Devices Market is expected to grow at the highest rate from 2023 to 2030. This is due to the rising incidence of cancer, the big populations in nations like China and India, the improved healthcare infrastructure, increased healthcare spending and government initiatives, and the increasing attention of major market participants in the region are all contributing to the segment's rise. Moreover, the China market of Biopsy Devices held the largest market share, and the Japan market of Biopsy Devices was the fastest-growing market in the Asia-Pacific region.
Key Players and Competitive Insights
Many global, regional, and local vendors characterize the biopsy device market. The market is highly competitive, with all the players competing to gain market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, product quality, reliability, and government regulations. Vendors must provide cost-efficient, high-quality polyamide products to survive and succeed in an intensely competitive market.
The market vendors’ growth depends on market conditions, government support, and industry development. Thus, the vendors should focus on expanding geographically and improving services. Argon Medical Devices (US), BD (US), Cook Medical (US), CONMED Corporation (US), Olympus Corporation (Japan), Hologic, Inc. (US), Cardinal Health Inc. (US), Integra LifeSciences (US), Medtronic plc (US), Mammotome (US), INRAD (US), and Trivitron Healthcare (India) are the major companies in the market that compete in terms of availability, quality, price, and technology. They primarily focus on the development of biopsy device products.
Although international players dominate the market, regional and foreign players with small market shares also have a presence. The international players may strengthen their presence worldwide through acquisitions during the forecast period.
Argon Medical Devices (US) is a global medical technology company that specializes in the development, manufacturing, and marketing of medical devices for interventional procedures. The company has a strong focus on providing innovative, high-quality products to healthcare professionals, and improving patient care. Argon Medical Devices offers a wide range of products, including vascular access devices, biopsy and drainage devices, and peripheral vascular devices.
Key Companies in the Biopsy Devices Market market include
Industry Developments
- Q2 2024: BD Launches New UltraCore™ Single-Use Biopsy Device for Improved Patient Safety Becton, Dickinson and Company (BD) announced the launch of its UltraCore™ single-use biopsy device, designed to enhance procedural safety and reduce infection risk in tissue sampling procedures.
- Q2 2024: Hologic Receives FDA Clearance for Brevera® Breast Biopsy System with CorLumina® Imaging Technology Hologic, Inc. received FDA clearance for its Brevera® Breast Biopsy System with CorLumina® Imaging Technology, enabling real-time imaging and improved workflow for breast tissue sampling.
- Q2 2024: Argon Medical Devices Announces Launch of SuperCore™ Advantage Biopsy Instrument Argon Medical Devices launched the SuperCore™ Advantage Biopsy Instrument, a new device designed to provide enhanced tissue yield and ease of use for clinicians performing soft tissue biopsies.
- Q2 2024: Merit Medical Launches Temno Evolution Biopsy Device with Single-Use Design Merit Medical Systems, Inc. introduced the Temno Evolution Biopsy Device, featuring a single-use, ergonomically contoured body to improve procedural safety and reduce the risk of cross-contamination.
- Q3 2024: INRAD, Inc. Announces FDA 510(k) Clearance for New MRI-Guided Biopsy Needle INRAD, Inc. received FDA 510(k) clearance for its new MRI-guided biopsy needle, expanding its portfolio of minimally invasive diagnostic tools for soft tissue sampling.
- Q3 2024: Siemens Healthineers and BioVentrix Announce Strategic Partnership to Advance Image-Guided Biopsy Solutions Siemens Healthineers and BioVentrix entered a strategic partnership to co-develop advanced image-guided biopsy solutions, aiming to improve diagnostic accuracy and patient outcomes.
- Q3 2024: Boston Scientific Appoints New President of Interventional Oncology and Biopsy Devices Division Boston Scientific Corporation announced the appointment of a new president to lead its Interventional Oncology and Biopsy Devices Division, signaling a renewed focus on innovation and market expansion.
- Q4 2024: MDxHealth Announces CE Mark for SelectMDx Prostate Biopsy Device in Europe MDxHealth received CE Mark approval for its SelectMDx Prostate Biopsy Device, allowing commercialization and clinical use across the European Union.
- Q4 2024: Cook Medical Opens New Biopsy Device Manufacturing Facility in Indiana Cook Medical opened a new manufacturing facility in Indiana dedicated to the production of biopsy devices, aiming to meet growing demand and improve supply chain resilience.
- Q1 2025: Veracyte Announces $50 Million Series D Funding to Expand Biopsy Diagnostics Portfolio Veracyte, Inc. raised $50 million in Series D funding to accelerate the development and commercialization of its biopsy diagnostics portfolio, including new minimally invasive tissue sampling technologies.
- Q1 2025: Roche Receives FDA Approval for NAVIFY® Biopsy Workflow Solution Roche announced FDA approval for its NAVIFY® Biopsy Workflow Solution, a digital platform designed to streamline and standardize the biopsy process in clinical settings.
- Q2 2025: BD Acquires BiopsyTech, Expanding Portfolio of Minimally Invasive Biopsy Devices Becton, Dickinson and Company (BD) completed the acquisition of BiopsyTech, a company specializing in minimally invasive biopsy devices, to strengthen its position in the global biopsy devices market.
Future Outlook
Biopsy Devices Market Future Outlook
<p>The Global Biopsy Devices Market is projected to grow at a 5.72% CAGR from 2024 to 2032, driven by technological advancements, increasing cancer prevalence, and rising demand for minimally invasive procedures.</p>
New opportunities lie in:
- <p>Invest in AI-driven biopsy technologies to enhance diagnostic accuracy and efficiency. Develop portable biopsy devices for point-of-care testing in remote areas. Expand product lines to include advanced imaging techniques for better tissue characterization.</p>
<p>By 2035, the market is expected to achieve substantial growth, reflecting advancements and increased adoption of innovative biopsy solutions.</p>
Market Segmentation
Biopsy Devices End User Outlook
- Hospitals & Clinics
- Diagnostic & Imaging Centers
- Academic & Research Institutes
- Others
Biopsy Devices Regional Outlook
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East
- Africa
- Latin America
Biopsy Devices Application Outlook
- Breast Biopsy
- Prostate Biopsy
- Liver Biopsy
- Lung Biopsy
- Gynecological Biopsy
- Others
Biopsy Devices Product Type Outlook
- {"Biopsy Needles"=>["Vacuum-Assisted Biopsy (VAB) Devices"
- "Fine Needle Aspiration Biopsy (FNAB) Devices"
- "Core Needle Biopsy (CNB) Devices"]}
Biopsy Devices Guidance Technique Outlook
- Ultrasound-Guided Biopsy
- Stereotactic Guided Biopsy
- MRI-Guided Biopsy
- CT Guided Biopsy
- Others
Report Scope
| Attribute/Metric | Details |
| Market Size 2024 | USD 2.81 billion |
| Market Size 2035 | 5.18 |
| Compound Annual Growth Rate (CAGR) | 5.72% (2025 - 2035) |
| Base Year | 2024 |
| Forecast Period | 2025 - 2035 |
| Historical Data | 2018-2022 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product Type, Application, Guidance Technique, End User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Argon Medical Devices (US), BD (US), Cook Medical (US), CONMED Corporation (US), Olympus Corporation (Japan), Hologic, Inc. (US), Cardinal Health Inc. (US), Integra LifeSciences (US), Medtronic plc (US), Mammotome (US), INRAD (US) and Trivitron Healthcare (India) |
| Key Market Opportunities | · Adoption of robotic assisted biopsy systems · Approval and launch of new products by key players |
| Key Market Dynamics | · Rising prevalence of cancer · Increasing preference for minimally invasive surgeries · Rise in government initiatives |
| Market Size 2025 | 2.97 |
Market Highlights
Author
Latest Comments
John Doe
john@example.com
This is a great article! Really helped me understand the topic better.
Posted on July 23, 2025, 10:15
AM
Jane Smith
jane@domain.com
Thanks for sharing this. I’ve bookmarked it for later reference.
Posted on July 22, 2025, 7:45
PM
FAQs
How much is the Biopsy Devices market?
The Biopsy Devices Market is anticipated to reach USD 4.4 billion at a CAGR of 5.72% during the forecast period of 2024 to 2032
What is the growth rate of the Biopsy Devices market?
The Biopsy Devices Market is expected to register a CAGR of 5.72% during the forecast period of 2024 to 2032.
Who are the key players in the Biopsy Devices market?
Argon Medical Devices (US), BD (US), Cook Medical (US), CONMED Corporation (US), Olympus Corporation (Japan), Hologic, Inc. (US), Cardinal Health Inc. (US), Integra LifeSciences (US), Medtronic plc (US), Mammotome (US), INRAD (US) and Trivitron Healthcare (India)
Which product type led the Biopsy Devices market?
The biopsy guns segment held the majority share in 2022 contributing to around 37.26% with respect to the Biopsy Devices Market
Which application had the largest market share in the Biopsy Devices market?
Breast biopsy segment dominated the market in 2022
-
--- "1 Introduction
- Definition
- Scope of Study
- Research Objective
- Assumptions & Limitations
- Market Structure:
-
Research Methodology
- Research Process
- Primary Research
- Secondary Research
-
Market Dynamics
- Drivers
- Restraints
- Opportunities
- Challenges
- Macroeconomic Indicators
-
Market Factor Analysis
-
Porter’s five forces model
- Bargaining Power of suppliers
- Bargaining Power of Customer
- Intensity of Competitor’s
- Threat of New Entrants
-
Porter’s five forces model
-
Global Biopsy Devices Market, by Product Type
-
Introduction
- Biopsy Guns
- Biopsy Guidance System
- Biopsy Needles
- Biopsy Forceps
- Others
-
Introduction
-
Global Biopsy Devices Market, by Application
-
Introduction
- Surgical biopsy
- Skin biopsy
- Needle biopsy
- Bone marrow biopsy
- Cancer Diagnosis
- Others
-
Introduction
-
Global Biopsy Devices Market, by End User
-
Introduction
- Hospitals
- Specialty Clinics
- Diagnostic centers Academic & Research Institutes
- Academic & Research Institutes
- Others
-
Introduction
-
Global Biopsy Devices Market, by Regions
-
Introduction
- Americas
- Europe
- Asia Pacific
- Middle East & Africa
-
Introduction
-
Company Landscape
-
Introduction
- Mergers Acquisitions
- Collaborations
- Release/New Product Launches
- Other (Expansion, Updates, Partnership)
-
Introduction
-
Company Profile
-
Argon Medical Devices, Inc.
- Company Overview
- Product/Business Segment Overview
- Financials
- Key Developments
- SWOT Analysis
-
BD
- Overview
- Product/Business Segment Overview
- Financials
- Key Developments
- SWOT Analysis
-
Cook Medical
- Overview
- Product/Business Segment Overview
- Financials
- Key Developments
- SWOT Analysis
-
C. R. Bard, Inc.
- Overview
- Product/Business Segment Overview
- Financials
- Key Developments
- SWOT Analysis
-
Creganna
- Overview
- Product/Business Segment Overview
- Financials
- Key Developments
- SWOT Analysis
-
Focal Therapeutics, Inc.
- Overview
- Product/Business Segment Overview
- Financials
- Key Developments
- SWOT Analysis
-
Hologic, Inc.
- Overview
- Product/Business Segment Overview
- Financials
- Key Developments
- SWOT Analysis
-
Integra LifeSciences Corporation
- Overview
- Product/Business Segment Overview
- Financials
- Key Developments
- SWOT Analysis
-
Leica Biosystems
- Overview
- Product/Business Segment Overview
- Financials
- Key Developments
- SWOT Analysis
-
Precision Biopsy, LLC
- Overview
- Product/Business Segment Overview
- Financials
- Key Developments
- SWOT Analysis
-
Scion Medical Technologies, LLC.
- Overview
- Product/Business Segment Overview
- Financials
- Key Developments
- SWOT Analysis
- Others
-
Argon Medical Devices, Inc.
-
Appendix
-
List of Tables and Figures
- List of Tables
- TABLE 1 GLOBAL BIOPSY DEVICES MARKET, 2020-2027 (USD MILLION)
- TABLE 2 GLOBAL BIOPSY DEVICES MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)
- TABLE 3 GLOBAL BIOPSY DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
- TABLE 4 GLOBAL BIOPSY DEVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
- TABLE 5 GLOBAL BIOPSY DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION) List of Figures
- FIGURE 1 RESEARCH PROCESS
- FIGURE 2 PORTERS FIVE FORCES MODEL
- FIGURE 3 GLOBAL BIOPSY DEVICES MARKET, BY PRODUCT TYPE
- FIGURE 4 GLOBAL BIOPSY DEVICES MARKET, BY APPLICATION
- FIGURE 5 GLOBAL BIOPSY DEVICES MARKET, BY END USER
- FIGURE 6 GLOBAL BIOPSY DEVICES MARKET, BY REGION
- FIGURE 7 GLOBAL BIOPSY DEVICES MARKET: COMPANY SHARE ANALYSIS, 2020 (%)"
Global Biopsy Devices Market Segmentation
Biopsy Devices Product Type Outlook (USD Billion, 2019-2030)
Biopsy Guns
Biopsy Guidance System
Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) Devices
Biopsy Forceps
Localization Wires
Others
Biopsy Devices Application Outlook (USD Billion, 2019-2030)
Breast Biopsy
Prostate Biopsy
Liver Biopsy
Lung Biopsy
Gynecological Biopsy
Others
Biopsy Devices Guidance Outlook (USD Billion, 2019-2030)
Ultrasound-Guided Biopsy
Stereotactic Guided Biopsy
MRI-Guided Biopsy
CT Guided Biopsy
Others
Biopsy Devices End User Outlook (USD Billion, 2019-2030)
Hospitals & Clinics
Diagnostic & Imaging Centers
Academic & Research Institutes
Others
Biopsy Devices Regional Outlook (USD Billion, 2019-2030)
North America Outlook (USD Billion, 2019-2030)
Biopsy Guns
Biopsy Guidance System
Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) Devices
Biopsy Forceps
Localization Wires
Others
North America Biopsy Devices by ApplicationBreast Biopsy
Prostate Biopsy
Liver Biopsy
Lung Biopsy
Gynecological Biopsy
Others
North America Biopsy Devices by Guidance TechniqueUltrasound-Guided Biopsy
Stereotactic Guided Biopsy
MRI-Guided Biopsy
CT Guided Biopsy
Others
North America Biopsy Devices by End UserHospitals & Clinics
Diagnostic & Imaging Centers
Academic & Research Institutes
Others
US Outlook (USD Billion, 2019-2030)
Biopsy Guns
Biopsy Guidance System
Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) Devices
Biopsy Forceps
Localization Wires
Others
US Biopsy Devices by ApplicationBreast Biopsy
Prostate Biopsy
Liver Biopsy
Lung Biopsy
Gynecological Biopsy
Others
US Biopsy Devices by Guidance TechniqueUltrasound-Guided Biopsy
Stereotactic Guided Biopsy
MRI-Guided Biopsy
CT Guided Biopsy
Others
US Biopsy Devices by End UserHospitals & Clinics
Diagnostic & Imaging Centers
Academic & Research Institutes
Others
Canada Outlook (USD Billion, 2019-2030)
Biopsy Guns
Biopsy Guidance System
Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) Devices
Biopsy Forceps
Localization Wires
Others
Canada Biopsy Devices by ApplicationBreast Biopsy
Prostate Biopsy
Liver Biopsy
Lung Biopsy
Gynecological Biopsy
Others
Canada Biopsy Devices by Guidance TechniqueUltrasound-Guided Biopsy
Stereotactic Guided Biopsy
MRI-Guided Biopsy
CT Guided Biopsy
Others
Canada Biopsy Devices by End UserHospitals & Clinics
Diagnostic & Imaging Centers
Academic & Research Institutes
Others
Europe Outlook (USD Billion, 2019-2030)
Biopsy Guns
Biopsy Guidance System
Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) Devices
Biopsy Forceps
Localization Wires
Others
Europe Biopsy Devices by ApplicationBreast Biopsy
Prostate Biopsy
Liver Biopsy
Lung Biopsy
Gynecological Biopsy
Others
Europe Biopsy Devices by Guidance TechniqueUltrasound-Guided Biopsy
Stereotactic Guided Biopsy
MRI-Guided Biopsy
CT Guided Biopsy
Others
Europe Biopsy Devices by End UserHospitals & Clinics
Diagnostic & Imaging Centers
Academic & Research Institutes
Others
Germany Outlook (USD Billion, 2019-2030)
Biopsy Guns
Biopsy Guidance System
Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) Devices
Biopsy Forceps
Localization Wires
Others
Germany Biopsy Devices by ApplicationBreast Biopsy
Prostate Biopsy
Liver Biopsy
Lung Biopsy
Gynecological Biopsy
Others
Germany Biopsy Devices by Guidance TechniqueUltrasound-Guided Biopsy
Stereotactic Guided Biopsy
MRI-Guided Biopsy
CT Guided Biopsy
Others
Germany Biopsy Devices by End UserHospitals & Clinics
Diagnostic & Imaging Centers
Academic & Research Institutes
Others
France Outlook (USD Billion, 2019-2030)
Biopsy Guns
Biopsy Guidance System
Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) Devices
Biopsy Forceps
Localization Wires
Others
France Biopsy Devices by ApplicationBreast Biopsy
Prostate Biopsy
Liver Biopsy
Lung Biopsy
Gynecological Biopsy
Others
France Biopsy Devices by Guidance TechniqueUltrasound-Guided Biopsy
Stereotactic Guided Biopsy
MRI-Guided Biopsy
CT Guided Biopsy
Others
France Biopsy Devices by End UserHospitals & Clinics
Diagnostic & Imaging Centers
Academic & Research Institutes
Others
UK Outlook (USD Billion, 2019-2030)
Biopsy Guns
Biopsy Guidance System
Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) Devices
Biopsy Forceps
Localization Wires
Others
UK Biopsy Devices by ApplicationBreast Biopsy
Prostate Biopsy
Liver Biopsy
Lung Biopsy
Gynecological Biopsy
Others
UK Biopsy Devices by Guidance TechniqueUltrasound-Guided Biopsy
Stereotactic Guided Biopsy
MRI-Guided Biopsy
CT Guided Biopsy
Others
UK Biopsy Devices by End UserHospitals & Clinics
Diagnostic & Imaging Centers
Academic & Research Institutes
Others
Italy Outlook (USD Billion, 2019-2030)
Biopsy Guns
Biopsy Guidance System
Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) Devices
Biopsy Forceps
Localization Wires
Others
Italy Biopsy Devices by ApplicationBreast Biopsy
Prostate Biopsy
Liver Biopsy
Lung Biopsy
Gynecological Biopsy
Others
Italy Biopsy Devices by Guidance TechniqueUltrasound-Guided Biopsy
Stereotactic Guided Biopsy
MRI-Guided Biopsy
CT Guided Biopsy
Others
Italy Biopsy Devices by End UserHospitals & Clinics
Diagnostic & Imaging Centers
Academic & Research Institutes
Others
Spain Outlook (USD Billion, 2019-2030)
Biopsy Guns
Biopsy Guidance System
Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) Devices
Biopsy Forceps
Localization Wires
Others
Spain Biopsy Devices by ApplicationBreast Biopsy
Prostate Biopsy
Liver Biopsy
Lung Biopsy
Gynecological Biopsy
Others
Spain Biopsy Devices by Guidance TechniqueUltrasound-Guided Biopsy
Stereotactic Guided Biopsy
MRI-Guided Biopsy
CT Guided Biopsy
Others
Spain Biopsy Devices by End UserHospitals & Clinics
Diagnostic & Imaging Centers
Academic & Research Institutes
Others
Rest Of Europe Outlook (USD Billion, 2019-2030)
Biopsy Guns
Biopsy Guidance System
Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) Devices
Biopsy Forceps
Localization Wires
Others
Rest of Europe Biopsy Devices by ApplicationBreast Biopsy
Prostate Biopsy
Liver Biopsy
Lung Biopsy
Gynecological Biopsy
Others
Rest of Europe Biopsy Devices by Guidance TechniqueUltrasound-Guided Biopsy
Stereotactic Guided Biopsy
MRI-Guided Biopsy
CT Guided Biopsy
Others
Rest of Europe Biopsy Devices by End UserHospitals & Clinics
Diagnostic & Imaging Centers
Academic & Research Institutes
Others
Asia-Pacific Outlook (USD Billion, 2019-2030)
Biopsy Guns
Biopsy Guidance System
Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) Devices
Biopsy Forceps
Localization Wires
Others
Asia-Pacific Biopsy Devices by ApplicationBreast Biopsy
Prostate Biopsy
Liver Biopsy
Lung Biopsy
Gynecological Biopsy
Others
Asia-Pacific Biopsy Devices by Guidance TechniqueUltrasound-Guided Biopsy
Stereotactic Guided Biopsy
MRI-Guided Biopsy
CT Guided Biopsy
Others
Asia-Pacific Biopsy Devices by End UserHospitals & Clinics
Diagnostic & Imaging Centers
Academic & Research Institutes
Others
China Outlook (USD Billion, 2019-2030)
Biopsy Guns
Biopsy Guidance System
Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) Devices
Biopsy Forceps
Localization Wires
Others
China Biopsy Devices by ApplicationBreast Biopsy
Prostate Biopsy
Liver Biopsy
Lung Biopsy
Gynecological Biopsy
Others
China Biopsy Devices by Guidance TechniqueUltrasound-Guided Biopsy
Stereotactic Guided Biopsy
MRI-Guided Biopsy
CT Guided Biopsy
Others
China Biopsy Devices by End UserHospitals & Clinics
Diagnostic & Imaging Centers
Academic & Research Institutes
Others
Japan Outlook (USD Billion, 2019-2030)
Biopsy Guns
Biopsy Guidance System
Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) Devices
Biopsy Forceps
Localization Wires
Others
Japan Biopsy Devices by ApplicationBreast Biopsy
Prostate Biopsy
Liver Biopsy
Lung Biopsy
Gynecological Biopsy
Others
Japan Biopsy Devices by Guidance TechniqueUltrasound-Guided Biopsy
Stereotactic Guided Biopsy
MRI-Guided Biopsy
CT Guided Biopsy
Others
Japan Biopsy Devices by End UserHospitals & Clinics
Diagnostic & Imaging Centers
Academic & Research Institutes
Others
India Outlook (USD Billion, 2019-2030)
Biopsy Guns
Biopsy Guidance System
Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) Devices
Biopsy Forceps
Localization Wires
Others
India Biopsy Devices by ApplicationBreast Biopsy
Prostate Biopsy
Liver Biopsy
Lung Biopsy
Gynecological Biopsy
Others
India Biopsy Devices by Guidance TechniqueUltrasound-Guided Biopsy
Stereotactic Guided Biopsy
MRI-Guided Biopsy
CT Guided Biopsy
Others
India Biopsy Devices by End UserHospitals & Clinics
Diagnostic & Imaging Centers
Academic & Research Institutes
Others
South Korea Outlook (USD Billion, 2019-2030)
Biopsy Guns
Biopsy Guidance System
Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) Devices
Biopsy Forceps
Localization Wires
Others
South Korea Biopsy Devices by ApplicationBreast Biopsy
Prostate Biopsy
Liver Biopsy
Lung Biopsy
Gynecological Biopsy
Others
South Korea Biopsy Devices by Guidance TechniqueUltrasound-Guided Biopsy
Stereotactic Guided Biopsy
MRI-Guided Biopsy
CT Guided Biopsy
Others
South Korea Biopsy Devices by End UserHospitals & Clinics
Diagnostic & Imaging Centers
Academic & Research Institutes
Others
Australia Outlook (USD Billion, 2019-2030)
Biopsy Guns
Biopsy Guidance System
Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) Devices
Biopsy Forceps
Localization Wires
Others
Australia Biopsy Devices by ApplicationBreast Biopsy
Prostate Biopsy
Liver Biopsy
Lung Biopsy
Gynecological Biopsy
Others
Australia Biopsy Devices by Guidance TechniqueUltrasound-Guided Biopsy
Stereotactic Guided Biopsy
MRI-Guided Biopsy
CT Guided Biopsy
Others
Australia Biopsy Devices by End UserHospitals & Clinics
Diagnostic & Imaging Centers
Academic & Research Institutes
Others
Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)
Biopsy Guns
Biopsy Guidance System
Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) Devices
Biopsy Forceps
Localization Wires
Others
Rest of Asia-Pacific Biopsy Devices by ApplicationBreast Biopsy
Prostate Biopsy
Liver Biopsy
Lung Biopsy
Gynecological Biopsy
Others
Rest of Asia-Pacific Biopsy Devices by Guidance TechniqueUltrasound-Guided Biopsy
Stereotactic Guided Biopsy
MRI-Guided Biopsy
CT Guided Biopsy
Others
Rest of Asia-Pacific Biopsy Devices by End UserHospitals & Clinics
Diagnostic & Imaging Centers
Academic & Research Institutes
Others
Rest of the World Outlook (USD Billion, 2019-2030)
Biopsy Guns
Biopsy Guidance System
Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) Devices
Biopsy Forceps
Localization Wires
Others
Rest of the World Biopsy Devices by ApplicationBreast Biopsy
Prostate Biopsy
Liver Biopsy
Lung Biopsy
Gynecological Biopsy
Others
Rest of the World Biopsy Devices by Guidance TechniqueUltrasound-Guided Biopsy
Stereotactic Guided Biopsy
MRI-Guided Biopsy
CT Guided Biopsy
Others
Rest of the World Biopsy Devices by End UserHospitals & Clinics
Diagnostic & Imaging Centers
Academic & Research Institutes
Others
Middle East Outlook (USD Billion, 2019-2030)
Biopsy Guns
Biopsy Guidance System
Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) Devices
Biopsy Forceps
Localization Wires
Others
Middle East Biopsy Devices by ApplicationBreast Biopsy
Prostate Biopsy
Liver Biopsy
Lung Biopsy
Gynecological Biopsy
Others
Middle East Biopsy Devices by Guidance TechniqueUltrasound-Guided Biopsy
Stereotactic Guided Biopsy
MRI-Guided Biopsy
CT Guided Biopsy
Others
Middle East Biopsy Devices by End UserHospitals & Clinics
Diagnostic & Imaging Centers
Academic & Research Institutes
Others
Africa Outlook (USD Billion, 2019-2030)
Biopsy Guns
Biopsy Guidance System
Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) Devices
Biopsy Forceps
Localization Wires
Others
Africa Biopsy Devices by ApplicationBreast Biopsy
Prostate Biopsy
Liver Biopsy
Lung Biopsy
Gynecological Biopsy
Others
Africa Biopsy Devices by Guidance TechniqueUltrasound-Guided Biopsy
Stereotactic Guided Biopsy
MRI-Guided Biopsy
CT Guided Biopsy
Others
Africa Biopsy Devices by End UserHospitals & Clinics
Diagnostic & Imaging Centers
Academic & Research Institutes
Others
Latin America Outlook (USD Billion, 2019-2030)
Biopsy Guns
Biopsy Guidance System
Biopsy Needles
Vacuum-Assisted Biopsy (VAB) Devices
Fine Needle Aspiration Biopsy (FNAB) Devices
Core Needle Biopsy (CNB) Devices
Biopsy Forceps
Localization Wires
Others
Latin America Biopsy Devices by ApplicationBreast Biopsy
Prostate Biopsy
Liver Biopsy
Lung Biopsy
Gynecological Biopsy
Others
Latin America Biopsy Devices by Guidance TechniqueUltrasound-Guided Biopsy
Stereotactic Guided Biopsy
MRI-Guided Biopsy
CT Guided Biopsy
Others
Latin America Biopsy Devices by End UserHospitals & Clinics
Diagnostic & Imaging Centers
Academic & Research Institutes
Others
Free Sample Request
Kindly complete the form below to receive a free sample of this Report
Customer Strories
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Leave a Comment